Do you want to read an article? Please log in or register.
Comparative Effectiveness of Multiple Different First-Line Treatment Regimens for Helicobacter pylori Infection: a Network Meta-Analysis
Helicobacter Pylori
Related content
Helicobacter Pylori
Comparison of four different regimens against Helicobacter pylori as a first-line treatment: A prospective, cross-sectional, comparative, open trial in Chinese children
Helicobacter.
Zhou Y, Ye Z, Wang Y, Zhang Y, Tang Z, Yan W, Jiang Y, Huang Y
doi: 10.1111/hel.12679.
Helicobacter Pylori
Pylera® plus ranitidine vs Pylera® plus esomeprazole in first-line treatment of Helicobacter pylori infection: Two pilot studies
Helicobacter.
Ciccaglione AF, Cellini L, Marzio L
doi: 10.1111/hel.12606.
Helicobacter Pylori
PPI-amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta-analysis
Helicobacter.
Gao CP, Zhang D, Zhang T, Wang JX, Han SX, Graham DY, Lu H
doi: 10.1111/hel.12692.
Helicobacter Pylori
Efficacy of bismuth added to standard triple therapy as the first-line eradication regimen for Helicobacter pylori infection
Helicobacter
Kim YJ, Chung WC, Kim DB
doi: 10.1111/hel.12792
Helicobacter Pylori
Helicobacter pylori first-line and rescue treatments in patients allergic to penicillin: Experience from the European Registry on H pylori management (Hp-EuReg)
Helicobacter.
Nyssen OP, Pérez-Aisa Á, Tepes B, Rodrigo-Sáez L, Romero PM, Lucendo A, Castro-Fernández M, Phull P, Barrio J, Bujanda L, Ortuño J, Areia M, Brglez Jurecic N, Huguet JM, Alcaide N, Voynovan I, María Botargues Bote J, Modolell I, Pérez Lasala J, Ariño I, Jonaitis L, Dominguez-Cajal M, Buzas G, Lerang F, Perona M, Bordin D, Axon T, Gasbarrini A, Marcos Pinto R, Niv Y, Kupcinskas L, Tonkic A, Leja M, Rokkas T, Boyanova L, Shvets O, Venerito M, Bytzer P, Goldis A, Simsek I, Lamy V, Przytulski K, Kunovský L, Capelle L, Milosavljevic T, Caldas M, Garre A, Mégraud F, O'Morain C, Gisbert JP, Hp-EuReg Investigators
doi: 10.1111/hel.12686.
Helicobacter Pylori
The effect of antibiotic resistance on Helicobacter pylori eradication efficacy: A systematic review and meta-analysis
Helicobacter.
Zou Y, Qian X, Liu X, Song Y, Song C, Wu S, An Y, Yuan R, Wang Y, Xie Y
doi: 10.1111/hel.12714.
RECOMMENDED
Inflammatory Bowel Disease
First- and Second-line Pharmacotherapies for Patients with Moderate to Severely Active Ulcerative Colitis: An Updated Network Meta-Analysis
★ 2
Recommended by
Prof. Dr Stephan Vavricka, Faculty Member
Clin Gastroenterol Hepatol.
Singh S, Murad MH, Fumery M, Dulai PS, Sandborn WJ
doi: 10.1016/j.cgh.2020.01.008.
Helicobacter Pylori
PPI-amoxicillin dual therapy four times daily is superior to guidelines recommended regimens in the Helicobacter pylori eradication therapy within Asia: A systematic review and meta-analysis
Helicobacter
Li C, Shi Y, Suo B, Tian X, Zhou L, Song Z
doi: 10.1111/hel.12816
Helicobacter Pylori
Seven-day vonoprazan and low-dose amoxicillin dual therapy as first-line Helicobacter pylori treatment: a multicentre randomised trial in Japan
Gut.
Suzuki S, Gotoda T, Kusano C, Ikehara H, Ichijima R, Ohyauchi M, Ito H, Kawamura M, Ogata Y, Ohtaka M, Nakahara M, Kawabe K
doi: 10.1136/gutjnl-2019-319954.